Not exact matches
As you know, on January 6, 2009 Millennium Technology Value Partners L.P. («Millennium») delivered a letter to the Board of Neurobiological Technologies, Inc. («NTI» or the «Company») urging it to take
immediate and decisive action to monetize and distribute the Company's remaining assets for the
benefit of
shareholders.
On January 6, 2009, in the context of the failure of the clinical trial for Viprinex, [NTII]'s primary asset, Millennium Technology Value Partners delivered a letter urging [NTII] to take
immediate and decisive action to monetize the remaining value of [NTII]'s assets for the
benefit of its
shareholders.
Shareholder confidence, organizational effectiveness, and employee engagement are just a few of the
immediate benefits of the right hire.